Related Experiment Video
Updated: Aug 14, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Effect of streptomycin administration on association of enteric pathogens with cecal tissue of mice
P Pongpech1, D J Hentges, W W Marsh
1Department of Microbiology, Texas Tech University, Lubbock 79430.
Abstract:
The effect of streptomycin on the ability of Shigella sonnei 3SR and enterotoxigenic Escherichia coli 2SR to associate with cecal tissue of mice in vivo and in vitro was examined. After orogastric challenge, both pathogens associated in significantly greater numbers (P less than or equal to 0.05) with the cecal tissue of streptomycin-treated mice than with the tissue of untreated mice. The population levels of the pathogens were also significantly greater (P less than or equal to 0.05) in the cecal contents of streptomycin-treated mice than in untreated mice. When excised cecal tissues from the two groups of mice were exposed to the pathogens in vitro, the extent of the association of the pathogens was markedly greater with tissues from streptomycin-treated mice than with tissues from untreated mice. There was also a positive correlation between the numbers of the pathogens in the suspending fluid and the extent of the tissue associations. The population size of fusiform organisms, which are the major components of the mucus layer of the ceca of mice, was reduced 100-fold by streptomycin administration. This was determined by microscopic count. Sections of cecal tissue obtained from the mice and stained with hematoxylin and eosin demonstrated that streptomycin administration greatly decreased the number of fusiform bacteria present in the mucosal microbial layer. We speculate that the partial elimination of fusiform organisms from this layer by streptomycin administration provides available association sites for pathogens so that they can successfully colonize the mouse cecum.
Insights
Streptomycin treatment increased pathogen colonization in mouse ceca by reducing native fusiform bacteria. This suggests antibiotic-induced microbiota disruption can enhance pathogen association with host tissues.
Area of Science:
- Microbiology
- Gastroenterology
- Pharmacology
Background:
- Antibiotic use can alter the gut microbiota.
- The cecum is a critical site for microbial colonization in mice.
Purpose of the Study:
- To investigate the effect of streptomycin on Shigella sonnei and enterotoxigenic Escherichia coli association with mouse cecal tissue.
- To explore the role of the native cecal microbiota in pathogen colonization.
Main Methods:
- In vivo and in vitro assays using streptomycin-treated and untreated mice.
- Microscopic examination of cecal tissue and contents.
- Quantification of pathogen and fusiform organism populations.
Main Results:
- Streptomycin significantly increased pathogen association with cecal tissue and population levels in cecal contents.
- In vitro studies showed greater pathogen adherence to cecal tissue from streptomycin-treated mice.
- Streptomycin drastically reduced the population of cecal fusiform organisms.
Conclusions:
- Streptomycin disrupts the native cecal microbiota, specifically reducing fusiform organisms.
- This disruption creates available binding sites, facilitating pathogen colonization of the mouse cecum.
- Alterations in the gut microbiome by antibiotics can impact host susceptibility to enteric pathogens.

